WEKO3
アイテム
{"_buckets": {"deposit": "b62fc45e-226f-4bcf-a3a6-963309beee82"}, "_deposit": {"created_by": 2, "id": "950", "owners": [2], "pid": {"revision_id": 0, "type": "depid", "value": "950"}, "status": "published"}, "_oai": {"id": "oai:nagasaki-u.repo.nii.ac.jp:00000950", "sets": ["11"]}, "author_link": ["4491", "4490"], "item_2_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2020-07-01", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "7", "bibliographicPageEnd": "612", "bibliographicPageStart": "603", "bibliographicVolumeNumber": "68", "bibliographic_titles": [{"bibliographic_title": "Chemical and Pharmaceutical Bulletin"}]}]}, "item_2_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Cancer treatments have improved significantly during the last decade but are not yet satisfactory. Combination therapy is often administered to improve efficacy and safety. Drug delivery systems can also improve efficacy and safety. To control the spatiotemporal distribution of drugs, nanotechnology involving liposomes, solid lipid nanoparticles, and polymeric micelles has been developed. Co-delivery systems of multiple drugs are a promising approach to combat cancer. Synergistic effects and reduced side effects are expected from the use of co-delivery systems. In this review, we summarize various co-delivery systems for multiple drugs, including small-molecule drugs, nucleic acids, genes, and proteins. Co-delivery of drugs with different properties is relatively difficult, but some researchers have succeeded in developing such co-delivery systems. Environment-responsive carrier designs can control the release of cargos. Although their preparation is more complicated than that of mono-delivery systems, co-delivery systems can simplify clinical procedures and improve patient QOL.", "subitem_description_type": "Abstract"}]}, "item_2_description_63": {"attribute_name": "引用", "attribute_value_mlt": [{"subitem_description": "Chemical \u0026 pharmaceutical bulletin, 68(7), pp.603-612; 2020", "subitem_description_type": "Other"}]}, "item_2_publisher_33": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "日本薬学会"}]}, "item_2_relation_12": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "10.1248/cpb.c20-00008", "subitem_relation_type_select": "DOI"}}]}, "item_2_rights_13": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "c 2020 The Pharmaceutical Society of Japan"}]}, "item_2_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "00092363", "subitem_source_identifier_type": "ISSN"}]}, "item_2_source_id_8": {"attribute_name": "EISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1347-5223", "subitem_source_identifier_type": "ISSN"}]}, "item_2_text_62": {"attribute_name": "出版者別言語", "attribute_value_mlt": [{"subitem_text_value": "Pharmaceutical Society of Japan"}]}, "item_2_version_type_16": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Fumoto, Shintaro"}], "nameIdentifiers": [{"nameIdentifier": "4490", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Nishida, Koyo"}], "nameIdentifiers": [{"nameIdentifier": "4491", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2020-12-18"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "CPBul68_603.pdf", "filesize": [{"value": "666.4 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_free", "mimetype": "application/pdf", "size": 666400.0, "url": {"label": "CPBul68_603.pdf", "url": "https://nagasaki-u.repo.nii.ac.jp/record/950/files/CPBul68_603.pdf"}, "version_id": "6db970e2-caad-48fb-829b-d461e610b700"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "liposome", "subitem_subject_scheme": "Other"}, {"subitem_subject": "polymer", "subitem_subject_scheme": "Other"}, {"subitem_subject": "small-molecule drug", "subitem_subject_scheme": "Other"}, {"subitem_subject": "DNA", "subitem_subject_scheme": "Other"}, {"subitem_subject": "RNA", "subitem_subject_scheme": "Other"}, {"subitem_subject": "protein", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy"}]}, "item_type_id": "2", "owner": "2", "path": ["11"], "permalink_uri": "http://hdl.handle.net/10069/40144", "pubdate": {"attribute_name": "公開日", "attribute_value": "2020-07-17"}, "publish_date": "2020-07-17", "publish_status": "0", "recid": "950", "relation": {}, "relation_version_is_last": true, "title": ["Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy"], "weko_shared_id": -1}
Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy
http://hdl.handle.net/10069/40144
http://hdl.handle.net/10069/401444db20121-4116-4a8a-98d9-e953826ea19e
名前 / ファイル | ライセンス | アクション |
---|---|---|
CPBul68_603.pdf (666.4 kB)
|
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2020-07-17 | |||||
タイトル | ||||||
タイトル | Co-delivery Systems of Multiple Drugs Using Nanotechnology for Future Cancer Therapy | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | liposome | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | polymer | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | small-molecule drug | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | DNA | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | RNA | |||||
キーワード | ||||||
主題Scheme | Other | |||||
主題 | protein | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
Fumoto, Shintaro
× Fumoto, Shintaro× Nishida, Koyo |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Cancer treatments have improved significantly during the last decade but are not yet satisfactory. Combination therapy is often administered to improve efficacy and safety. Drug delivery systems can also improve efficacy and safety. To control the spatiotemporal distribution of drugs, nanotechnology involving liposomes, solid lipid nanoparticles, and polymeric micelles has been developed. Co-delivery systems of multiple drugs are a promising approach to combat cancer. Synergistic effects and reduced side effects are expected from the use of co-delivery systems. In this review, we summarize various co-delivery systems for multiple drugs, including small-molecule drugs, nucleic acids, genes, and proteins. Co-delivery of drugs with different properties is relatively difficult, but some researchers have succeeded in developing such co-delivery systems. Environment-responsive carrier designs can control the release of cargos. Although their preparation is more complicated than that of mono-delivery systems, co-delivery systems can simplify clinical procedures and improve patient QOL. | |||||
書誌情報 |
Chemical and Pharmaceutical Bulletin 巻 68, 号 7, p. 603-612, 発行日 2020-07-01 |
|||||
出版者 | ||||||
出版者 | 日本薬学会 | |||||
出版者別言語 | ||||||
Pharmaceutical Society of Japan | ||||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 00092363 | |||||
EISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 1347-5223 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | 10.1248/cpb.c20-00008 | |||||
権利 | ||||||
権利情報 | c 2020 The Pharmaceutical Society of Japan | |||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
引用 | ||||||
内容記述タイプ | Other | |||||
内容記述 | Chemical & pharmaceutical bulletin, 68(7), pp.603-612; 2020 |